11/11/2010

VHIR's researchers published the results of two recent studies that shed some light on the importance of genetics in Alzheimer's disease. One study explains how the existence of genetic factors determining individual differences in response to estrogen exposure. The other study highlights how the gene CALMH1 seems to be related to the age of onset of the disease. All these new findings, published recently in the journal Neurobiology of Aging and Journal of Alzheimer's Disease respectively, positioned Alzheimer's research in terms that suggest that we are facing drug-genomic strategies for addressing this disease. Although it is still premature to consider treatment of these features, it seems clear that genetic differences will be key in relation to risk, evolution and individual and gender differences detected in relation to these variables in this disease.